Invitrocue Ltd.

Invitrocue Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.01
Market Cap
AUD34.15 M
Shares Outstanding
525.33 M
Public Float
-

Profile

Address
350 Kent Street
Sydney New South Wales (NSW) 2000
Australia
Employees -
Website http://www.invitrocue.com
Updated 07/08/2019
Invitrocue Ltd. provides bio analytic solutions including in vitro cell-based testing technologies and image analytics software for use in digital pathology. The company focuses on the commercialization of its bio analytics services using cell based model and imaging based technology. Its cell based services enable pharmaceutical and cosmetics companies to refine their drug, ingredient, compound or vaccine discovery efforts and digital pathology business offers solutions, including slide scanning and digitisation; image analytics of tissues and cell samples; pathology consultation with board certified pathologists, and telepathology via an online web-based portal.

Financials

View All

Andreas Lindner
Non-Executive Director
Hanry Yu
Director